Trial Profile
An effectiveness study of the combination of dapagliflozin and liraglutide in NAFLD patients with T2DM compared with dapagliflozin, liraglutide, sitagliptin, and pioglitazone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Liraglutide (Primary) ; Metformin; Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 18 Oct 2018 New trial record
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes